Seth Bagshaw
Analyst · Deutsche Bank. Your line is open
Thank you, John. I’ll cover our Q3 2019 financial results and discuss our Q4 2019 guidance. Sales for third quarter of $462 million at the high-end of the guidance range, a decrease of 2% sequentially compares to the second quarter. Sales to semiconductor customers with $223 million, an increase of 4% sequentially as we continue to see positive signs in the semi market. Sales for Advanced Markets were $239 million, a decrease of 8% sequentially was impacted by the general slowdown in industrial markets, as well as uncertainty caused by global trade tensions. Sales to life and health sciences in research and defense markets remain steady in the third quarter. 52% of our sales for the customers in our advanced markets were 48% with customers in the semiconductor market, consistent with our long-term goal achieving our balanced market mix. GAAP and non-GAAP gross margin were 44.3% within our expectations of this revenue volume, non-GAAP operating expenses were $124 million, which were favorable to the mid-point of our guidance due to continuing focus on managing our cost structure. Non-GAAP operating margin was 17.6%, which was almost 200 basis points favorable in the midpoint of our guidance range. This continued strong financial performance reflects our ability to effectively manage the company from all stages of the operating cycle. GAAP operating expenses were $138 million, include $17 million in amortization of intangible assets, $2.1 million in acquisitions and integration cost, $1.5 million in restructuring cost and $600,000 in transaction fees associated with the repricing of our term loan. In addition, we recorded a $6.8 million gain from sale of certain real estate holdings as we continue to streamline our geographic footprint. GAAP net interest expense was $13.5 million and non-GAAP net interest expense was $10.5 million. Our GAAP tax rate was 14.4%, and our non-GAAP tax rate was 15.6%. Tax rates were lower than our expectations due to mix of geographical income and we expect these rates to return to more normalized levels in the fourth quarter. GAAP net income was $47 million, or $0.80 per diluted share and non-GAAP net earnings was $62 million or $1.12 per diluted share. The integration of ESI acquisition continues to proceed very well and as in the third quarter we achieved $12 million annualized cost synergies. We’ are on schedule to realize the $15 million of announced total annualized cost synergies within the next 12 to 18 months. In the third quarter, revenue and equipment solutions division was $49 million, which was also within our expectations. Now turning to the balance sheet, in September, successfully repriced our – we successfully completed our fifth repricing of our term loan, which reduced the interest rate spread on two existing tranches from LIBOR plus 2% and LIBOR plus 2.5% respectively to LIBOR plus 1.75% and combined two tranches into one tranche maturity date in February 2026. In addition, we made a $50 million voluntary prepayment of principal on our term loan at September 30, an outstanding balance of $895 million. The most recent voluntary prepayment is our 10th since loan origination in April 2016. The repricing in voluntary prepayment reduces our annualized non-GAAP interest cost by almost $6 million based on current interest rates. As in the quarter, we maintain a strong balance sheet liquidity for $435 million of cash and investments, $100 million of incremental borrowing capacity under an asset-based line of credit, and a modest 12-month net leverage ratio of under one-time. Free cash flow for the quarter was $44 million. We continue to demonstrate a balanced approach of capital deployments, and in the quarter, we paid a cash dividend of $10.9 million or $0.20 per share. In terms of working capital, day sales outstanding was 65 days at the end of the third quarter, compared to 60 days at the end of the second quarter. Inventory turns were 2.2 times or consistent with second quarter. Finally, I will discuss our Q4 2019 guidance. Based upon current business levels, we estimate that our sales in the fourth quarter ranged from $445 million to $495 million and a non-GAAP gross to range from 42.5% to 44.5%. The expected gross margin is slightly lower in the fourth quarter due to both seasonally lower volumes in product mix with the equipment solutions division. We expect our gross margin to return to normalized levels by the first quarter of next year. Q4 non-GAAP operating expenses could range from $121 million to $129 million. R&D expenses could range from $40.5 million to $43.5 million, and SG&A expenses could range from $80.5 million to $85.5 million. Non-GAAP interest expense is expected to be approximately $8.9 million and our non-GAAP tax rate is expected to be approximately 21%. Given these assumptions, fourth quarter non-GAAP net earnings could range $47 million to $66 million or $0.85 to $1.19 per diluted share. In the fourth quarter, amortization of intangible assets is expected to be approximately $17.1 million, the integration-related costs are expected to be approximately $1.9 million. Interest income is expected to be approximately $1 million, and GAAP interest expense estimated to be approximately $9.1 million. GAAP net income is expected to range $32 million to $50 million or $0.58 and $0.91 per diluted share or approximately 55.3 million shares outstanding. I like to now turn the call back to Jerry for his final thoughts before we move to Q&A.